Phase 2 ADHD Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are between 18 and 55 years old
• Your body mass index (BMI) is between 18 and 35 (a measure of body weight relative to height)
• You scored 4 or above on a standard ADHD self-report questionnaire called the ASRS-v1.1 Part A
• You have been assessed and meet the recognised criteria for ADHD, with at least mild symptoms, based on a specific diagnostic interview (confirm with trial site)
• You are not pregnant and are not currently breastfeeding
• You are willing to use effective contraception (such as the pill, double barrier method, or an IUD) for 30 days before and 30 days after the study
• You are willing to stop using cannabis or any product containing THC for the entire duration of the study
• You are willing to keep your current medications the same throughout the study — no starting or stopping treatments
• You have access to transportation to the University of Arkansas campus for study appointments
• You are willing to follow any COVID-19 safety guidelines in place at the university (such as wearing a mask)

Who may not be able to join:

• You are currently pregnant or breastfeeding
• You have a history of significant allergic reactions to cannabis, cannabinoid medicines, hemp products, medium chain triglyceride oil, or peppermint
• You have used CBG or any other cannabinoid product in the past 30 days
• You have ever used a synthetic cannabinoid product, such as dronabinol, nabilone, spice, or K2
• You have taken part in another clinical trial or used an experimental drug or device in the past 30 days, or plan to do so during this study
• You are currently taking or have been prescribed ADHD medication in the past six months
• You are currently having thoughts of suicide
• You currently have severe major depression or a substance use disorder
• You have been diagnosed with bipolar disorder or psychosis
• You currently have an acute illness (such as a respiratory infection) or are taking medication for one (such as antibiotics)
• You have a history of liver problems or significantly reduced liver function (such as cirrhosis or hepatitis)
• You have any serious or unstable physical health conditions, including neurological or kidney illness
• You have any current or past heart or cardiovascular conditions, including low blood pressure, a slow heart rate, or heart block
• An ECG (heart trace) taken during your visit shows irregular heart rhythms such as atrial fibrillation, slow heart rate, or fast heart rate
• You have used recreational drugs (other than cannabis) or alcohol in the 12 hours before your in-person study visit
• You are currently taking any of the following medications: Warfarin, Clobazam, Valproic acid, Phenobarbital, mTOR inhibitors, oral Tacrolimus, St. John's Wort, Epidiolex, Escitalopram, heart or cardiovascular medications, or strong CYP3A4 inhibitors such as Ketoconazole (confirm with trial site if unsure about your medications)

Important: Always verify eligibility with the trial site directly before applying.